Notice Number: NOT-TR-19-025
Key Dates
Release Date: July 05, 2019
NOT-TR-19-018
Issued by
National Center for Advancing Translational Sciences (NCATS)
Purpose
The purpose of this Notice is to change the Eligible Organizations and Information for Foreign Institutions for HEAL Initiative: Announcement of Collaboration Opportunities for Developing Drugs and Human Cell-Based Testing Platforms for Pain, Addiction and Overdose NOT-TR-19-018.
Currently Reads:
SUBMISSION AND FUNDING INFORMATION
Proposal submission is a two-step process. Potential collaborators submit a 2-page pdf pre-proposal to the email address below to allow NCATS scientists to determine if the proposed project fits with the goals of the Developing Drugs and Human Cell-Based Testing Platforms for Pain, Addiction and Overdose program and the NCATS laboratories’ capabilities.
The NCATS DPI operational model is built on collaboration among components of NIH and external partners. Collaborators bring actionable existing data and disease knowledge to the collaboration, but lack either the expertise or resources to enable discovery. In-kind support will be provided by the NCATS laboratories/programs.
ELIGIBLE ORGANIZATIONS
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small business
Eligible Agencies of the Federal Government, including NIH intramural laboratories
FOREIGN INSTITUTIONS
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Prospective collaborators are encouraged to review the technical assistance slide deck available at https://ncats.nih.gov/heal/intramural-capabilities. Additional information about this collaboration opportunity will be available at: https://ncats.nih.gov/heal/funding.
Revised to read:
SUBMISSION AND FUNDING INFORMATION
Proposal submission is a two-step process. Potential collaborators submit a 2-page pdf pre-proposal to the email address below to allow NCATS scientists to determine if the proposed project fits with the goals of the Developing Drugs and Human Cell-Based Testing Platforms for Pain, Addiction and Overdose program and the NCATS laboratories’ capabilities.
The NCATS DPI operational model is built on collaboration among components of NIH and external partners. Collaborators bring actionable existing data and disease knowledge to the collaboration, but lack either the expertise or resources to enable discovery. In-kind support will be provided by the NCATS laboratories/programs.
ELIGIBLE ORGANIZATIONS
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small business
For-Profit Organizations (Other than Small Businesses)
Eligible Agencies of the Federal Government, including NIH intramural laboratories
FOREIGN INSTITUTIONS
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Prospective collaborators are encouraged to review the technical assistance slide deck available at https://ncats.nih.gov/heal/intramural-capabilities. Additional information about this collaboration opportunity will be available at: https://ncats.nih.gov/heal/funding.
Inquiries
Please direct all inquiries to:
Steven Pittenger, PhD
National Center for Advancing Translational Sciences (NCATS)
Email: [email protected]
and Human Services (HHS)
